Skip to main content
Top
Published in: Obesity Surgery 5/2019

01-05-2019 | Endoscopy | Original Contributions

Systematic Endoscopy 5 Years After Sleeve Gastrectomy Results in a High Rate of Barrett’s Esophagus: Results of a Multicenter Study

Authors: Lionel Sebastianelli, Marine Benois, Geoffroy Vanbiervliet, Laurent Bailly, Maud Robert, Nicolas Turrin, Emmanuel Gizard, Mirto Foletto, Marco Bisello, Alice Albanese, Antonella Santonicola, Paola Iovino, Thierry Piche, Luigi Angrisani, Laurent Turchi, Luigi Schiavo, Antonio Iannelli

Published in: Obesity Surgery | Issue 5/2019

Login to get access

Abstract

Background

Recent evidence has indicated an increased risk of Barrett’s esophagus (BE) in the long term after sleeve gastrectomy (SG).

Aim

The aim of the study is to investigate the spectrum of gastroesophageal reflux disease (GERD) symptoms as well as the prevalence of BE, at minimum 5 years after SG in patients who underwent SG in different bariatric centers of two countries: France and Italy.

Patients and Methods

Five high volume outpatient centers dedicated to bariatric surgery that routinely perform upper GI endoscopy before any bariatric procedures were invited to participate in the study. From January 2017 to June 2018, each center during scheduled postoperative evaluation after surgery asked a minimum 10 consecutive patients, which had performed SG at least 5 years before and with no evidence of BE preoperatively, to undergo another upper GI endoscopy.

Results

Ninety (66 F) consecutive patients were enrolled. The mean follow-up was 78 ± 15 months, and the mean total body weight loss was 25 ± 12%. The prevalence of BE was 18.8% with no significant difference among centers. Weight loss failure was significantly associated with BE (p < 0.01). The prevalence of GERD symptoms, erosive esophagitis, and the usage of PPIs increased from 22%, 10%, and 22% before the SG to 76%, 41%, and 52% at the time of follow-up, respectively (p < 0.05).

Conclusions

This multicenter study show a high rate of BE at least 5 years after SG. Weight loss failure was significantly associated with BE. We suggest to provide systematic endoscopy in these patients to rule out this condition.
Literature
2.
go back to reference Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.CrossRefPubMedPubMedCentral Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.CrossRefPubMedPubMedCentral
5.
go back to reference Iannelli A, Sans A, Martini F, et al. Hiatal hernia, GERD, and sleeve gastrectomy: a complex interplay. Obes Surg. 2016;26(10):2485–7.CrossRefPubMed Iannelli A, Sans A, Martini F, et al. Hiatal hernia, GERD, and sleeve gastrectomy: a complex interplay. Obes Surg. 2016;26(10):2485–7.CrossRefPubMed
6.
go back to reference Oor JE, Roks DJ, Ünlü Ç, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016;211(1):250–67.CrossRefPubMed Oor JE, Roks DJ, Ünlü Ç, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016;211(1):250–67.CrossRefPubMed
7.
go back to reference Hendricks L, Alvarenga E, Dhanabalsamy N, et al. Impact of sleeve gastrectomy on gastroesophageal reflux disease in a morbidly obese population undergoing bariatric surgery. Surg Obes Relat Dis. 2016;12(3):511–7.CrossRefPubMed Hendricks L, Alvarenga E, Dhanabalsamy N, et al. Impact of sleeve gastrectomy on gastroesophageal reflux disease in a morbidly obese population undergoing bariatric surgery. Surg Obes Relat Dis. 2016;12(3):511–7.CrossRefPubMed
8.
go back to reference Eisen GM, Sandler RS, Murray S, et al. The relationship between gastroesophageal reflux disease and its complications with Barrett’s esophagus. Am J Gastroenterol. 1997;92(1):27–31.PubMed Eisen GM, Sandler RS, Murray S, et al. The relationship between gastroesophageal reflux disease and its complications with Barrett’s esophagus. Am J Gastroenterol. 1997;92(1):27–31.PubMed
9.
go back to reference Drahos J, Li L, Jick SS, et al. Metabolic syndrome in relation to Barrett’s esophagus and esophageal adenocarcinoma: results from a large population-based case-control study in the Clinical Practice Research Datalink. Cancer Epidemiol. 2016;42:9–14.CrossRefPubMedPubMedCentral Drahos J, Li L, Jick SS, et al. Metabolic syndrome in relation to Barrett’s esophagus and esophageal adenocarcinoma: results from a large population-based case-control study in the Clinical Practice Research Datalink. Cancer Epidemiol. 2016;42:9–14.CrossRefPubMedPubMedCentral
10.
go back to reference Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74.CrossRefPubMed Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74.CrossRefPubMed
11.
go back to reference Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017;27(12):3092–101.CrossRefPubMed Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017;27(12):3092–101.CrossRefPubMed
12.
go back to reference Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825–31.CrossRefPubMed Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825–31.CrossRefPubMed
14.
go back to reference Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392–9.CrossRefPubMed Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392–9.CrossRefPubMed
15.
go back to reference Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017;49(2):191–8.CrossRefPubMed Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017;49(2):191–8.CrossRefPubMed
16.
go back to reference Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.CrossRefPubMed Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.CrossRefPubMed
17.
go back to reference Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40(3):275–85.CrossRefPubMed Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40(3):275–85.CrossRefPubMed
18.
go back to reference Sharma A, Aggarwal S, Ahuja V, et al. Evaluation of gastroesophageal reflux before and after sleeve gastrectomy using symptom scoring, scintigraphy, and endoscopy. Surg Obes Relat Dis. 2014;10(4):600–5.CrossRefPubMed Sharma A, Aggarwal S, Ahuja V, et al. Evaluation of gastroesophageal reflux before and after sleeve gastrectomy using symptom scoring, scintigraphy, and endoscopy. Surg Obes Relat Dis. 2014;10(4):600–5.CrossRefPubMed
19.
go back to reference Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg. 2014;260(5):909–14.CrossRefPubMed Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg. 2014;260(5):909–14.CrossRefPubMed
20.
21.
go back to reference Lazoura O, Zacharoulis D, Triantafyllidis G, et al. Symptoms of gastroesophageal reflux following laparoscopic sleeve gastrectomy are related to the final shape of the sleeve as depicted by radiology. Obes Surg. 2011;21(3):295–9.CrossRefPubMed Lazoura O, Zacharoulis D, Triantafyllidis G, et al. Symptoms of gastroesophageal reflux following laparoscopic sleeve gastrectomy are related to the final shape of the sleeve as depicted by radiology. Obes Surg. 2011;21(3):295–9.CrossRefPubMed
22.
go back to reference Melissas J, Braghetto I, Molina JC, et al. Gastroesophageal reflux disease and sleeve gastrectomy. Obes Surg. 2015;25(12):2430–5.CrossRefPubMed Melissas J, Braghetto I, Molina JC, et al. Gastroesophageal reflux disease and sleeve gastrectomy. Obes Surg. 2015;25(12):2430–5.CrossRefPubMed
23.
go back to reference Soricelli E, Casella G, Baglio G, et al. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy. Surg Obes Relat Dis. 2018;14(6):751–6.CrossRefPubMed Soricelli E, Casella G, Baglio G, et al. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy. Surg Obes Relat Dis. 2018;14(6):751–6.CrossRefPubMed
24.
go back to reference Steevens J, Schouten LJ, Driessen ALC, et al. A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett’s esophagus. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2011;20(2):345–58.CrossRef Steevens J, Schouten LJ, Driessen ALC, et al. A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett’s esophagus. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2011;20(2):345–58.CrossRef
25.
go back to reference Gatenby P, Ramus J, Caygill C, et al. Routinely diagnosed low-grade dysplasia in Barrett’s oesophagus: a population-based study of natural history. Histopathology. 2009;54(7):814–9.CrossRefPubMed Gatenby P, Ramus J, Caygill C, et al. Routinely diagnosed low-grade dysplasia in Barrett’s oesophagus: a population-based study of natural history. Histopathology. 2009;54(7):814–9.CrossRefPubMed
26.
go back to reference Rastogi A, Puli S, El-Serag HB, et al. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008;67(3):394–8.CrossRefPubMed Rastogi A, Puli S, El-Serag HB, et al. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008;67(3):394–8.CrossRefPubMed
27.
go back to reference Angrisani L, Santonicola A, Hasani A, et al. Five-year results of laparoscopic sleeve gastrectomy: effects on gastroesophageal reflux disease symptoms and co-morbidities. Surg Obes Relat Dis. 2016;12(5):960–8.CrossRefPubMed Angrisani L, Santonicola A, Hasani A, et al. Five-year results of laparoscopic sleeve gastrectomy: effects on gastroesophageal reflux disease symptoms and co-morbidities. Surg Obes Relat Dis. 2016;12(5):960–8.CrossRefPubMed
28.
go back to reference Wright FG, Duro A, Medici JR, et al. D. Esophageal adenocarcinoma five years after laparoscopic sleeve gastrectomy. A case report. Int J Surg Case Rep. 2017;32:47–50.CrossRefPubMedPubMedCentral Wright FG, Duro A, Medici JR, et al. D. Esophageal adenocarcinoma five years after laparoscopic sleeve gastrectomy. A case report. Int J Surg Case Rep. 2017;32:47–50.CrossRefPubMedPubMedCentral
29.
go back to reference Gagner M. Is sleeve gastrectomy always an absolute contraindication in patients with Barrett’s? Obes Surg. 2016;26(4):715–7.CrossRefPubMed Gagner M. Is sleeve gastrectomy always an absolute contraindication in patients with Barrett’s? Obes Surg. 2016;26(4):715–7.CrossRefPubMed
30.
go back to reference Lagergren J, Mattsson F, Nyrén O. Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12(1):45–51. Lagergren J, Mattsson F, Nyrén O. Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12(1):45–51.
31.
go back to reference Gagner M, Braghetto I. A symposium on management of Barrett’s in patients having bariatric surgery. Obes Surg. 2016;26(4):709.CrossRefPubMed Gagner M, Braghetto I. A symposium on management of Barrett’s in patients having bariatric surgery. Obes Surg. 2016;26(4):709.CrossRefPubMed
32.
go back to reference Frezza EE, Ikramuddin S, Gourash W, et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2002;16(7):1027–31.CrossRefPubMed Frezza EE, Ikramuddin S, Gourash W, et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2002;16(7):1027–31.CrossRefPubMed
33.
go back to reference Braghetto I, Csendes A. Patients having bariatric surgery: surgical options in morbidly obese patients with Barrett’s esophagus. Obes Surg. 2016;26(7):1622–6.CrossRefPubMed Braghetto I, Csendes A. Patients having bariatric surgery: surgical options in morbidly obese patients with Barrett’s esophagus. Obes Surg. 2016;26(7):1622–6.CrossRefPubMed
34.
go back to reference Parikh K, Khaitan L. Radiofrequency ablation coupled with Roux-en-Y gastric bypass: a treatment option for morbidly obese patients with Barrett’s esophagus. J Surg Case Rep. 2016;2016 (3). Parikh K, Khaitan L. Radiofrequency ablation coupled with Roux-en-Y gastric bypass: a treatment option for morbidly obese patients with Barrett’s esophagus. J Surg Case Rep. 2016;2016 (3).
Metadata
Title
Systematic Endoscopy 5 Years After Sleeve Gastrectomy Results in a High Rate of Barrett’s Esophagus: Results of a Multicenter Study
Authors
Lionel Sebastianelli
Marine Benois
Geoffroy Vanbiervliet
Laurent Bailly
Maud Robert
Nicolas Turrin
Emmanuel Gizard
Mirto Foletto
Marco Bisello
Alice Albanese
Antonella Santonicola
Paola Iovino
Thierry Piche
Luigi Angrisani
Laurent Turchi
Luigi Schiavo
Antonio Iannelli
Publication date
01-05-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 5/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-03704-y

Other articles of this Issue 5/2019

Obesity Surgery 5/2019 Go to the issue